Psychiatric symptoms improved significantly within 16 days of inpatient cannabis detoxification
In 35 chronic cannabis users undergoing supervised detox, psychiatric symptoms improved substantially within 16 days, though patients rated their own distress higher than clinicians observed.
Quick Facts
What This Study Found
Thirty-five chronic cannabis-dependent individuals were monitored during inpatient detoxification using both clinician-rated and self-reported psychiatric scales. At admission, nearly 90% showed no or only mild depression, anxiety, or manic symptoms on clinician-rated scales. However, about 60% described strong psychiatric distress in self-reports.
All patients improved significantly within 16 days. Effect sizes ranged from 0.7 to 1.4 (Cohen's d), indicating medium to large improvements across all measures. THC blood levels at admission were associated with cognitive impairment and motor retardation but not with mood or anxiety symptoms.
The discrepancy between clinician observations and self-reports was attributed to withdrawal syndrome effects and executive dysfunction, which may alter patients' ability to accurately assess their own mental state.
Key Numbers
35 patients studied. 90% showed mild or no clinician-rated psychiatric symptoms at admission. 60% self-reported strong psychiatric burden. Effect sizes 0.7-1.4 (Cohen's d) for improvement over 16 days. THC levels predicted cognitive impairment and motor retardation.
How They Did This
Prospective observational study of 35 treatment-seeking chronic cannabis-dependent patients (ICD-10 criteria) without active comorbid psychiatric conditions. Assessed at admission and on abstinence days 8 and 16 using HAMD, HAMA, YMRS, BPRS, and SCL-90-R. Serum THC and metabolites measured simultaneously.
Why This Research Matters
This study provides a timeline for psychiatric improvement during supervised cannabis withdrawal. The 16-day improvement window and the discrepancy between how patients feel versus how they appear to clinicians are both clinically useful for managing expectations during detox.
The Bigger Picture
Cannabis withdrawal is often perceived as mild compared to other substances, but this study shows patients experience significant subjective distress that may not be apparent to clinicians. Recognizing this gap helps improve clinical care during detoxification.
What This Study Doesn't Tell Us
Small sample of 35 patients. No control group. Patients were treatment-seeking and free of active comorbid conditions, which limits generalizability. Sixteen days may not capture the full duration of withdrawal symptoms.
Questions This Raises
- ?Do psychiatric symptoms continue improving beyond 16 days?
- ?Why do patients rate their distress so much higher than clinicians observe?
- ?Would longer monitoring reveal a different trajectory for cognitive symptoms?
Trust & Context
- Key Stat:
- Effect sizes 0.7-1.4 for psychiatric improvement within 16 days
- Evidence Grade:
- Small prospective observational study without a control group. Findings are descriptive of the detox experience.
- Study Age:
- Published in 2015 using inpatient detoxification data.
- Original Title:
- Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
- Published In:
- Drug and alcohol dependence, 155, 302-6 (2015)
- Authors:
- Bonnet, Udo(8), Borda, Thorsten, Scherbaum, Norbert(7), Specka, Michael
- Database ID:
- RTHC-00926
Evidence Hierarchy
Enrolls participants and follows them forward in time.
What do these levels mean? →Frequently Asked Questions
How long do cannabis withdrawal symptoms last?
In this study, significant psychiatric improvement occurred within 16 days of supervised abstinence, with medium to large effect sizes. However, 16 days may not capture the complete withdrawal timeline for all individuals.
Why might I feel worse than I look during cannabis withdrawal?
This study found patients rated their psychiatric distress much higher than clinician observations showed. The researchers attributed this gap to withdrawal effects and executive dysfunction that may alter self-perception.
Read More on RethinkTHC
- 30-days-without-weed
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- anger-irritability-quitting-weed-withdrawal
- appetite-after-quitting-weed
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- caffeine-weed-withdrawal
- cannabinoid-hyperemesis-syndrome
- cannabis-withdrawal-complete-guide
- cannabis-withdrawal-severity-levels-mild-moderate-severe
- cannabis-withdrawal-syndrome
- cannabis-withdrawal-syndrome-dsm-5
- cannabis-withdrawal-syndrome-timeline-day-by-day
- cannabis-withdrawal-vs-alcohol-nicotine-opioid-comparison
- creativity-without-weed-quitting-artist-musician
- emotional-after-quitting-weed-crying
- first-week-quitting-weed
- hobbies-after-quitting-weed
- how-long-does-weed-withdrawal-last
- how-long-to-feel-normal-after-quitting-weed
- identity-after-quitting-weed
- leaving-stoner-culture-identity
- marijuana-withdrawal-symptoms
- money-saved-quitting-weed-calculator
- night-sweats-quitting-weed-withdrawal
- one-year-sober-weed
- paws-cannabis-post-acute-withdrawal
- quitting-weed-creativity
- quitting-weed-face-changes-skin
- quitting-weed-weight-loss-gain
- weed-cravings
- weed-depersonalization-derealization
- weed-paws-withdrawal
- weed-withdrawal-anger
- weed-withdrawal-brain-fog
- weed-withdrawal-chest-tightness-heart-palpitations
- weed-withdrawal-crying-emotional
- weed-withdrawal-depression
- weed-withdrawal-headaches
- weed-withdrawal-irritability
- weed-withdrawal-men
- weed-withdrawal-mood-swings
- weed-withdrawal-nausea
- weed-withdrawal-night-sweats
- weed-withdrawal-no-appetite
- weed-withdrawal-sweating-detox
- weed-withdrawal-timeline
- weed-withdrawal-vs-alcohol
- weed-withdrawal-women
- what-happens-when-you-stop-smoking-weed
Cite This Study
https://rethinkthc.com/research/RTHC-00926APA
Bonnet, Udo; Borda, Thorsten; Scherbaum, Norbert; Specka, Michael. (2015). Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.. Drug and alcohol dependence, 155, 302-6. https://doi.org/10.1016/j.drugalcdep.2015.08.003
MLA
Bonnet, Udo, et al. "Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.." Drug and alcohol dependence, 2015. https://doi.org/10.1016/j.drugalcdep.2015.08.003
RethinkTHC
RethinkTHC Research Database. "Abstinence phenomena of chronic cannabis-addicts prospective..." RTHC-00926. Retrieved from https://rethinkthc.com/research/bonnet-2015-abstinence-phenomena-of-chronic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.